MetaADEDB 2.0 @ LMMD
Itraconazole
(VHVPQPYKVGDNFY-AVQIMAJZSA-N)
Structure
SMILES
CCC(n1ncn(c1=O)c1ccc(cc1)N1CCN(CC1)c1ccc(cc1)OC[C@@H]1CO[C@@](O1)(Cn1cncn1)c1ccc(cc1Cl)Cl)C
Molecular Formula:
C35H38Cl2N8O4
Molecular Weight:
705.633
Log P:
5.7073
Hydrogen Bond Acceptor:
12
Hydrogen Bond Donor:
0
TPSA:
104.7
CAS Number(s):
84625-61-6
Synonym(s)
1.
Itraconazole
2.
Orungal
3.
R-51211
4.
Sporanox
5.
R 51211
6.
R51211
External Link(s)
MeSHD017964
PubChem Compound6917738
Therapeutic Target DatabaseD0V4IB
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Blood creatine phosphokinase increasedFAERS: 24US FAERS
2Erythema MultiformeFAERS: 14US FAERS
3PneumoniaFAERS: 13US FAERS
4Alanine Aminotransferase IncreasedFAERS: 10US FAERS
5Aspartate Aminotransferase IncreasedFAERS: 10US FAERS
6MalaiseFAERS: 10US FAERS
7Stevens-Johnson SyndromeFAERS: 10US FAERS
8Blood lactate dehydrogenase increasedFAERS: 9US FAERS
9PruritusFAERS: 7US FAERS
10jaundiceFAERS: 7US FAERS
11Abdominal PainFAERS: 6US FAERS
12Atrioventricular BlockFAERS: 6US FAERS
13Blood creatinine increasedFAERS: 6US FAERS
14ErythemaFAERS: 6US FAERS
15White blood cell count decreasedFAERS: 6US FAERS
16Blood glucose increasedFAERS: 5US FAERS
17Blood triglycerides increasedFAERS: 5US FAERS
18HeadacheFAERS: 5US FAERS
19Myocardial InfarctionFAERS: 5US FAERS
20Respiratory distressFAERS: 5US FAERS
21ThrombocytopeniaFAERS: 5US FAERS
22TinnitusFAERS: 5US FAERS
23ChokingFAERS: 4US FAERS
24CholecystitisFAERS: 4US FAERS
25DizzinessFAERS: 4US FAERS
26Drug ineffectiveFAERS: 4US FAERS
27EosinophiliaFAERS: 4US FAERS
28LeukopeniaFAERS: 4US FAERS
29MyalgiaFAERS: 4US FAERS
30TremorFAERS: 4US FAERS
31Weight decreasedFAERS: 4US FAERS
32AzoospermiaFAERS: 3US FAERS
33Blood potassium increasedFAERS: 3US FAERS
34BradycardiaFAERS: 3US FAERS
35Chest PainFAERS: 3US FAERS
36FatigueFAERS: 3US FAERS
37Gamma-Glutamyltransferase IncreasedFAERS: 3US FAERS
38HypotensionFAERS: 3US FAERS
39Inappropriate schedule of drug administrationFAERS: 3US FAERS
40Intentional drug misuseFAERS: 3US FAERS
41LymphadenopathyFAERS: 3US FAERS
42NasopharyngitisFAERS: 3US FAERS
43Nephrotic SyndromeFAERS: 3US FAERS
44PancreatitisFAERS: 3US FAERS
45PancytopeniaFAERS: 3US FAERS
46Pulmonary EmbolismFAERS: 3US FAERS
47PurpuraFAERS: 3US FAERS
48RhabdomyolysisFAERS: 3US FAERS
49Altered state of consciousnessFAERS: 2US FAERS
50AmnesiaFAERS: 2US FAERS
51Angina PectorisFAERS: 2US FAERS
52AnxietyFAERS: 2US FAERS
53ArthralgiaFAERS: 2US FAERS
54AstheniaFAERS: 2US FAERS
55Back PainFAERS: 2US FAERS
56Beta 2 microglobulin increasedFAERS: 2US FAERS
57Beta-N-acetyl-D-glucosaminidase increasedFAERS: 2US FAERS
58Blood potassium decreasedFAERS: 2US FAERS
59Blood urea increasedFAERS: 2US FAERS
60Bronchopulmonary AspergillosisFAERS: 2US FAERS
61Cerebral InfarctionFAERS: 2US FAERS
62Choking sensationFAERS: 2US FAERS
63ColitisFAERS: 2US FAERS
64Cystitis-like symptomFAERS: 2US FAERS
65DeafnessFAERS: 2US FAERS
66Diabetes MellitusFAERS: 2US FAERS
67Drug exposure during pregnancyFAERS: 2US FAERS
68Drug level decreasedFAERS: 2US FAERS
69Drug prescribing errorFAERS: 2US FAERS
70EpistaxisFAERS: 2US FAERS
71Eye painFAERS: 2US FAERS
72HypersensitivityFAERS: 2US FAERS
73Incorrect route of drug administrationFAERS: 2US FAERS
74Injection site extravasationFAERS: 2US FAERS
75LeukodermaFAERS: 2US FAERS
76Medication ErrorFAERS: 2US FAERS
77Myoglobin blood increasedFAERS: 2US FAERS
78NephrolithiasisFAERS: 2US FAERS
79Oculomucocutaneous syndromeFAERS: 2US FAERS
80OsteoporosisFAERS: 2US FAERS
81PalpitationsFAERS: 2US FAERS
82Pharyngolaryngeal PainFAERS: 2US FAERS
83Pneumatosis intestinalisFAERS: 2US FAERS
84PneumothoraxFAERS: 2US FAERS
85Product use in unapproved indicationFAERS: 2US FAERS
86Respiratory FailureFAERS: 2US FAERS
87SepsisFAERS: 2US FAERS
88Sinus bradycardiaFAERS: 2US FAERS
89SomnolenceFAERS: 2US FAERS
90StomatitisFAERS: 2US FAERS
91UlcerFAERS: 2US FAERS
92Urinary RetentionFAERS: 2US FAERS
93VertigoFAERS: 2US FAERS
94Wrong technique in product usage processFAERS: 2US FAERS
95Adverse eventFAERS: 1US FAERS
96Ammonia increasedFAERS: 1US FAERS
97Anaphylactoid ReactionFAERS: 1US FAERS
98AnuriaFAERS: 1US FAERS
99Aphthous StomatitisFAERS: 1US FAERS
100AppendicitisFAERS: 1US FAERS
101AspergillomaFAERS: 1US FAERS
102Blood amylase increasedFAERS: 1US FAERS
103Blood creatinine decreasedFAERS: 1US FAERS
104BursitisFAERS: 1US FAERS
105Calcium deficiencyFAERS: 1US FAERS
106CandidiasisFAERS: 1US FAERS
107Carcinoembryonic antigen increasedFAERS: 1US FAERS
108Cardiac HypertrophyFAERS: 1US FAERS
109CardiomegalyFAERS: 1US FAERS
110Carotid Artery ThrombosisFAERS: 1US FAERS
111Cerebrovascular accidentFAERS: 1US FAERS
112Chronic respiratory failureFAERS: 1US FAERS
113Clostridium colitisFAERS: 1US FAERS
114Clostridium difficile colitisFAERS: 1US FAERS
115Cold sweatFAERS: 1US FAERS
116Congenital HydrocephalusFAERS: 1US FAERS
117ConjunctivitisFAERS: 1US FAERS
118Coronary artery embolismFAERS: 1US FAERS
119CystFAERS: 1US FAERS
120Deafness NeurosensoryFAERS: 1US FAERS
121DementiaFAERS: 1US FAERS
122Depressed Level of ConsciousnessFAERS: 1US FAERS
123Device related infectionFAERS: 1US FAERS
124Disseminated Intravascular CoagulationFAERS: 1US FAERS
125Double ureterFAERS: 1US FAERS
126Drug administered to patient of inappropriate ageFAERS: 1US FAERS
127Drug administration errorFAERS: 1US FAERS
128Drug exposure before pregnancyFAERS: 1US FAERS
129DysarthriaFAERS: 1US FAERS
130DysgeusiaFAERS: 1US FAERS
131EczemaFAERS: 1US FAERS
132Electrolyte imbalanceFAERS: 1US FAERS
133Eosinophilic PneumoniaFAERS: 1US FAERS
134Eye opacityFAERS: 1US FAERS
135Factor VIII DeficiencyFAERS: 1US FAERS
136FlatulenceFAERS: 1US FAERS
137FlushingFAERS: 1US FAERS
138Gamma-glutamyltransferase abnormalFAERS: 1US FAERS
139Gastric ulcerFAERS: 1US FAERS
140GoutFAERS: 1US FAERS
141Helicobacter test positiveFAERS: 1US FAERS
142HepatitisFAERS: 1US FAERS
143HyperthyroidismFAERS: 1US FAERS
144HypophagiaFAERS: 1US FAERS
145Incorrect dose administeredFAERS: 1US FAERS
146Incorrect drug administration durationFAERS: 1US FAERS
147Infusion Site ExtravasationFAERS: 1US FAERS
148Infusion site erythemaFAERS: 1US FAERS
149Infusion site painFAERS: 1US FAERS
150Infusion site swellingFAERS: 1US FAERS
151Injection site movement impairmentFAERS: 1US FAERS
152Joint swellingFAERS: 1US FAERS
153LacerationFAERS: 1US FAERS
154Lichen PlanusFAERS: 1US FAERS
155Lymphocyte count decreasedFAERS: 1US FAERS
156Lymphocyte stimulation test positiveFAERS: 1US FAERS
157MYELODYSPLASTIC SYNDROMEFAERS: 1US FAERS
158Mallory-Weiss SyndromeFAERS: 1US FAERS
159Monocyte count increasedFAERS: 1US FAERS
160Musculoskeletal stiffnessFAERS: 1US FAERS
161MyocarditisFAERS: 1US FAERS
162MyoclonusFAERS: 1US FAERS
163MyopathyFAERS: 1US FAERS
164NauseaFAERS: 1US FAERS
165NecrosisFAERS: 1US FAERS
166Negative cardiac inotropic effectFAERS: 1US FAERS
167Neutrophil count decreasedFAERS: 1US FAERS
168No adverse eventFAERS: 1US FAERS
169Oral mucosal exfoliationFAERS: 1US FAERS
170Pancreatic carcinomaFAERS: 1US FAERS
171ParesisFAERS: 1US FAERS
172Pathogen resistanceFAERS: 1US FAERS
173Peripheral swellingFAERS: 1US FAERS
174PeritonsillitisFAERS: 1US FAERS
175PetechiaeFAERS: 1US FAERS
176Prescription drug used without a prescriptionFAERS: 1US FAERS
177Product administration errorFAERS: 1US FAERS
178Product closure removal difficultFAERS: 1US FAERS
179Product dose omissionFAERS: 1US FAERS
180Psychiatric symptomFAERS: 1US FAERS
181Pulmonary HypertensionFAERS: 1US FAERS
182Pulmonary artery thrombosisFAERS: 1US FAERS
183Pulmonary granulomaFAERS: 1US FAERS
184PyelonephritisFAERS: 1US FAERS
185Renal painFAERS: 1US FAERS
186Renal tubular disorderFAERS: 1US FAERS
187Retinal DetachmentFAERS: 1US FAERS
188ScabFAERS: 1US FAERS
189Semen volume decreasedFAERS: 1US FAERS
190Senile dementiaFAERS: 1US FAERS
191Septic ShockFAERS: 1US FAERS
192ShockFAERS: 1US FAERS
193Sick Sinus SyndromeFAERS: 1US FAERS
194Skin UlcerFAERS: 1US FAERS
195SluggishnessFAERS: 1US FAERS
196Stress ulcerFAERS: 1US FAERS
197Systemic mycosisFAERS: 1US FAERS
198ThrombosisFAERS: 1US FAERS
199ThyroiditisFAERS: 1US FAERS
200Tinea PedisFAERS: 1US FAERS
201Trichosporon infectionFAERS: 1US FAERS
202Urethral strictureFAERS: 1US FAERS
203Urinary hesitationFAERS: 1US FAERS
204Vagus Nerve DisorderFAERS: 1US FAERS
205VomitingFAERS: 1US FAERS
206Wound infection staphylococcalFAERS: 1US FAERS
207liposarcomaFAERS: 1US FAERS
208pseudomembranous colitisFAERS: 1US FAERS
209skin abrasionFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120295

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.